(NewsDirect)
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF)CEO Christopher von Jako speaks to Thomas Warner from Proactive afterthe medical imaging technology company announced its first de novoorder for its XENOVIEW polariser.
Von Jako explains that the latest order, from a renowned medicalinstitution in the Northeast, represents a significant step as it isfrom a brand new customer. Von Jako, who took the helm in July, alsohighlights the company's work with Dutch multinational Philips,emphasising the seamless integration of their products, includingFDA-approved MRI coils.
Thiscollaboration extends to training Philips' commercial staff in theU.S., promising further growth in 2024. Additionally, Polarean ispursuing strategic growth initiatives, including increasingutilisation of their technology at sites like CincinnatiChildren's Hospital and the University of Missouri.
The company is also focusing on expandingits footprint and establishing Medicare reimbursement, thus enhancingits financial viability. Another key initiative involves conducting aclinical trial for FDA approval to explore new lung functions,potentially revolutionising lung imaging technology.
In terms offinancials, von Jako expressed confidence in closing the funding gapby the third quarter of the next year, supported by strategicinvestors.
Contact Details
Proactive UKLtd
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.